ReviewNature reviews. Clinical oncology2021
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
170 papers cite itlatest 60 shown
this paperpooled ittrialcites it